Home » Topics » BioWorld Science

BioWorld Science
RSS

Jiangsu Wanbang Biopharmaceutical cleared to begin clinical trials of SGLT2 inhibitor in China

July 13, 2018

Recruitment open for phase IIa study of Nerofe for AML and MDS

July 13, 2018

Roche presents phase II data for olesoxime in patients with SMA

July 13, 2018

Shenzhen Chipscreen Biosciences patents indoleamine 2,3-dioxygenase 1 inhibitors

July 13, 2018

Lilly presents IDH1 and IDH2 mutant inhibitors

July 13, 2018

N-Acetyl-beta-D-glucosaminidase inhibitors identified at Janssen

July 13, 2018

Ono Pharmaceutical initiates phase I study of ONO-5788

July 13, 2018

Audentes Therapeutics presents phase I/II data on AT-132 for XLMTM

July 13, 2018

Positive topline data presented from second pivotal phase III study of ZX-008 in Dravet Syndrome

July 13, 2018

Yale University develops novel SV2A radiotracer for PET imaging of synaptic density

July 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...